Investors Capital Advisory Services’s AbbVie ABBV Stock Holding History

Investors Capital Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.2M	Buy	19,416 +806	+4%	+$49.1K	0.23%	115
2016 Q1	$1.06M	Buy	18,610 +4,450	+31%	+$248K	0.21%	132
2015 Q4	$836K	Sell	14,160 -3,638	-20%	-$210K	0.16%	182
2015 Q3	$965K	Buy	17,798 +602	+4%	+$39.2K	0.19%	142
2015 Q2	$1.15M	Sell	17,196 -2,167	-11%	-$141K	0.21%	130
2015 Q1	$1.13M	Sell	19,363 -638	-3%	-$38.5K	0.21%	127
2014 Q4	$1.31M	Buy	20,001 +5,355	+37%	+$338K	0.25%	106
2014 Q3	$845K	Sell	14,646 -326	-2%	-$18.1K	0.17%	177
2014 Q2	$844K	Buy	14,972 +757	+5%	+$39.7K	0.14%	231
2014 Q1	$730K	Buy	14,215 +551	+4%	+$27.8K	0.16%	194
2013 Q4	$721K	Buy	13,664 +1,181	+9%	+$58K	0.17%	180
2013 Q3	$558K	Sell	12,483 -346	-3%	-$15.3K	0.14%	214
2013 Q2	$529K	Buy	+12,829	New	+$561K	0.16%	180

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Investors Capital Advisory Services's ABBV Position: Q2 2016 in Review

Investors Capital Advisory Services increased its AbbVie (ABBV) stake by 4.3% in Q2 2016, buying an estimated $49.1K and bringing the position to 19,416 shares worth $1.2M. The position accounts for 0.23% of the portfolio, ranked #115.

Investors Capital Advisory Services first reported a position in ABBV in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.31M in Q4 2014. 1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

Investors Capital Advisory Services held 19,416 shares of AbbVie worth $1.2M as of Q2 2016.
Investors Capital Advisory Services bought 806 AbbVie shares in Q2 2016, an estimated $49.1K.
AbbVie made up 0.23% of Investors Capital Advisory Services's portfolio in Q2 2016, its #115 holding.
Investors Capital Advisory Services first reported a position in AbbVie in Q2 2013 and has held it in 13 quarters since.
Investors Capital Advisory Services's AbbVie position peaked at $1.31M in Q4 2014.
1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.